Edition:
United Kingdom

Celsion Corp announces positive DSMB review of Phase 1B ovation study in ovarian cancer


Thursday, 1 Dec 2016 

Celsion Corp : Celsion Corporation announces positive DSMB review of Phase 1B ovation study in ovarian cancer . Celsion - study to continue as planned, co to proceed with completing dosing in fourth and final patient cohort, which is currently enrolling patients. .Celsion Corp - expect to report final data from ovation study C in Q1 of 2017.